0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cyclin Dependent Kinase 1 Market Research Report 2023
Published Date: March 2023
|
Report Code: QYRE-Auto-5Y7284
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cyclin Dependent Kinase 1 Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cyclin Dependent Kinase 1 Market Research Report 2023

Code: QYRE-Auto-5Y7284
Report
March 2023
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Cyclin Dependent Kinase 1 Market

The global Cyclin Dependent Kinase 1 market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Cyclin Dependent Kinase 1 is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Cyclin Dependent Kinase 1 is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Cyclin Dependent Kinase 1 include Astex Pharmaceuticals Inc, ChoDang Pharm Co Ltd, Presage Biosciences Inc, Tiziana Life Sciences Plc and Tragara Pharmaceuticals Inc, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cyclin Dependent Kinase 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclin Dependent Kinase 1.
The Cyclin Dependent Kinase 1 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cyclin Dependent Kinase 1 market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cyclin Dependent Kinase 1 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Key Segmentations

By Company

  • Astex Pharmaceuticals Inc
  • ChoDang Pharm Co Ltd
  • Presage Biosciences Inc
  • Tiziana Life Sciences Plc
  • Tragara Pharmaceuticals Inc

Segment by Type

  • AT-7519
  • CD-650
  • Milciclib
  • Others

Segment by Application

  • Relapsed Chronic Lymphocytic Leukemia
  • Gliosarcoma
  • Lymphoma
  • Others

Consumption by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cyclin Dependent Kinase 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cyclin Dependent Kinase 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

Scope of Global Cyclin Dependent Kinase 1 Market Report

Report MetricDetails
Report NameGlobal Cyclin Dependent Kinase 1 Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Cyclin Dependent Kinase 1 Market Overview
1.1 Product Overview and Scope of Cyclin Dependent Kinase 1
1.2 Cyclin Dependent Kinase 1 Segment by Type
1.2.1 Global Cyclin Dependent Kinase 1 Market Value Comparison by Type (2023-2029)
1.2.2 AT-7519
1.2.3 CD-650
1.2.4 Milciclib
1.2.5 Others
1.3 Cyclin Dependent Kinase 1 Segment by Application
1.3.1 Global Cyclin Dependent Kinase 1 Market Value by Application: (2023-2029)
1.3.2 Relapsed Chronic Lymphocytic Leukemia
1.3.3 Gliosarcoma
1.3.4 Lymphoma
1.3.5 Others
1.4 Global Cyclin Dependent Kinase 1 Market Size Estimates and Forecasts
1.4.1 Global Cyclin Dependent Kinase 1 Revenue 2018-2029
1.4.2 Global Cyclin Dependent Kinase 1 Sales 2018-2029
1.4.3 Global Cyclin Dependent Kinase 1 Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Cyclin Dependent Kinase 1 Market Competition by Manufacturers
2.1 Global Cyclin Dependent Kinase 1 Sales Market Share by Manufacturers (2018-2023)
2.2 Global Cyclin Dependent Kinase 1 Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Cyclin Dependent Kinase 1 Average Price by Manufacturers (2018-2023)
2.4 Global Cyclin Dependent Kinase 1 Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Cyclin Dependent Kinase 1, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cyclin Dependent Kinase 1, Product Type & Application
2.7 Cyclin Dependent Kinase 1 Market Competitive Situation and Trends
2.7.1 Cyclin Dependent Kinase 1 Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cyclin Dependent Kinase 1 Players Market Share by Revenue
2.7.3 Global Cyclin Dependent Kinase 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cyclin Dependent Kinase 1 Retrospective Market Scenario by Region
3.1 Global Cyclin Dependent Kinase 1 Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Cyclin Dependent Kinase 1 Global Cyclin Dependent Kinase 1 Sales by Region: 2018-2029
3.2.1 Global Cyclin Dependent Kinase 1 Sales by Region: 2018-2023
3.2.2 Global Cyclin Dependent Kinase 1 Sales by Region: 2024-2029
3.3 Global Cyclin Dependent Kinase 1 Global Cyclin Dependent Kinase 1 Revenue by Region: 2018-2029
3.3.1 Global Cyclin Dependent Kinase 1 Revenue by Region: 2018-2023
3.3.2 Global Cyclin Dependent Kinase 1 Revenue by Region: 2024-2029
3.4 North America Cyclin Dependent Kinase 1 Market Facts & Figures by Country
3.4.1 North America Cyclin Dependent Kinase 1 Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Cyclin Dependent Kinase 1 Sales by Country (2018-2029)
3.4.3 North America Cyclin Dependent Kinase 1 Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cyclin Dependent Kinase 1 Market Facts & Figures by Country
3.5.1 Europe Cyclin Dependent Kinase 1 Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Cyclin Dependent Kinase 1 Sales by Country (2018-2029)
3.5.3 Europe Cyclin Dependent Kinase 1 Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cyclin Dependent Kinase 1 Market Facts & Figures by Country
3.6.1 Asia Pacific Cyclin Dependent Kinase 1 Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Cyclin Dependent Kinase 1 Sales by Country (2018-2029)
3.6.3 Asia Pacific Cyclin Dependent Kinase 1 Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cyclin Dependent Kinase 1 Market Facts & Figures by Country
3.7.1 Latin America Cyclin Dependent Kinase 1 Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Cyclin Dependent Kinase 1 Sales by Country (2018-2029)
3.7.3 Latin America Cyclin Dependent Kinase 1 Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cyclin Dependent Kinase 1 Market Facts & Figures by Country
3.8.1 Middle East and Africa Cyclin Dependent Kinase 1 Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Cyclin Dependent Kinase 1 Sales by Country (2018-2029)
3.8.3 Middle East and Africa Cyclin Dependent Kinase 1 Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cyclin Dependent Kinase 1 Sales by Type (2018-2029)
4.1.1 Global Cyclin Dependent Kinase 1 Sales by Type (2018-2023)
4.1.2 Global Cyclin Dependent Kinase 1 Sales by Type (2024-2029)
4.1.3 Global Cyclin Dependent Kinase 1 Sales Market Share by Type (2018-2029)
4.2 Global Cyclin Dependent Kinase 1 Revenue by Type (2018-2029)
4.2.1 Global Cyclin Dependent Kinase 1 Revenue by Type (2018-2023)
4.2.2 Global Cyclin Dependent Kinase 1 Revenue by Type (2024-2029)
4.2.3 Global Cyclin Dependent Kinase 1 Revenue Market Share by Type (2018-2029)
4.3 Global Cyclin Dependent Kinase 1 Price by Type (2018-2029)
5 Segment by Application
5.1 Global Cyclin Dependent Kinase 1 Sales by Application (2018-2029)
5.1.1 Global Cyclin Dependent Kinase 1 Sales by Application (2018-2023)
5.1.2 Global Cyclin Dependent Kinase 1 Sales by Application (2024-2029)
5.1.3 Global Cyclin Dependent Kinase 1 Sales Market Share by Application (2018-2029)
5.2 Global Cyclin Dependent Kinase 1 Revenue by Application (2018-2029)
5.2.1 Global Cyclin Dependent Kinase 1 Revenue by Application (2018-2023)
5.2.2 Global Cyclin Dependent Kinase 1 Revenue by Application (2024-2029)
5.2.3 Global Cyclin Dependent Kinase 1 Revenue Market Share by Application (2018-2029)
5.3 Global Cyclin Dependent Kinase 1 Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Astex Pharmaceuticals Inc
6.1.1 Astex Pharmaceuticals Inc Corporation Information
6.1.2 Astex Pharmaceuticals Inc Description and Business Overview
6.1.3 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product Portfolio
6.1.5 Astex Pharmaceuticals Inc Recent Developments/Updates
6.2 ChoDang Pharm Co Ltd
6.2.1 ChoDang Pharm Co Ltd Corporation Information
6.2.2 ChoDang Pharm Co Ltd Description and Business Overview
6.2.3 ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Sales, Revenue and Gross Margin (2018-2023)
6.2.4 ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Product Portfolio
6.2.5 ChoDang Pharm Co Ltd Recent Developments/Updates
6.3 Presage Biosciences Inc
6.3.1 Presage Biosciences Inc Corporation Information
6.3.2 Presage Biosciences Inc Description and Business Overview
6.3.3 Presage Biosciences Inc Cyclin Dependent Kinase 1 Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Presage Biosciences Inc Cyclin Dependent Kinase 1 Product Portfolio
6.3.5 Presage Biosciences Inc Recent Developments/Updates
6.4 Tiziana Life Sciences Plc
6.4.1 Tiziana Life Sciences Plc Corporation Information
6.4.2 Tiziana Life Sciences Plc Description and Business Overview
6.4.3 Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Product Portfolio
6.4.5 Tiziana Life Sciences Plc Recent Developments/Updates
6.5 Tragara Pharmaceuticals Inc
6.5.1 Tragara Pharmaceuticals Inc Corporation Information
6.5.2 Tragara Pharmaceuticals Inc Description and Business Overview
6.5.3 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product Portfolio
6.5.5 Tragara Pharmaceuticals Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cyclin Dependent Kinase 1 Industry Chain Analysis
7.2 Cyclin Dependent Kinase 1 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cyclin Dependent Kinase 1 Production Mode & Process
7.4 Cyclin Dependent Kinase 1 Sales and Marketing
7.4.1 Cyclin Dependent Kinase 1 Sales Channels
7.4.2 Cyclin Dependent Kinase 1 Distributors
7.5 Cyclin Dependent Kinase 1 Customers
8 Cyclin Dependent Kinase 1 Market Dynamics
8.1 Cyclin Dependent Kinase 1 Industry Trends
8.2 Cyclin Dependent Kinase 1 Market Drivers
8.3 Cyclin Dependent Kinase 1 Market Challenges
8.4 Cyclin Dependent Kinase 1 Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Cyclin Dependent Kinase 1 Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Cyclin Dependent Kinase 1 Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Cyclin Dependent Kinase 1 Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Cyclin Dependent Kinase 1 Sales (K Pcs) of Key Manufacturers (2018-2023)
    Table 5. Global Cyclin Dependent Kinase 1 Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Cyclin Dependent Kinase 1 Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Cyclin Dependent Kinase 1 Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Cyclin Dependent Kinase 1 Average Price (USD/Pcs) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Cyclin Dependent Kinase 1, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Cyclin Dependent Kinase 1, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Cyclin Dependent Kinase 1, Product Type & Application
    Table 12. Global Key Manufacturers of Cyclin Dependent Kinase 1, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Cyclin Dependent Kinase 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclin Dependent Kinase 1 as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Cyclin Dependent Kinase 1 Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Cyclin Dependent Kinase 1 Sales by Region (2018-2023) & (K Pcs)
    Table 18. Global Cyclin Dependent Kinase 1 Sales Market Share by Region (2018-2023)
    Table 19. Global Cyclin Dependent Kinase 1 Sales by Region (2024-2029) & (K Pcs)
    Table 20. Global Cyclin Dependent Kinase 1 Sales Market Share by Region (2024-2029)
    Table 21. Global Cyclin Dependent Kinase 1 Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Cyclin Dependent Kinase 1 Revenue Market Share by Region (2018-2023)
    Table 23. Global Cyclin Dependent Kinase 1 Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Cyclin Dependent Kinase 1 Revenue Market Share by Region (2024-2029)
    Table 25. North America Cyclin Dependent Kinase 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Cyclin Dependent Kinase 1 Sales by Country (2018-2023) & (K Pcs)
    Table 27. North America Cyclin Dependent Kinase 1 Sales by Country (2024-2029) & (K Pcs)
    Table 28. North America Cyclin Dependent Kinase 1 Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Cyclin Dependent Kinase 1 Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Cyclin Dependent Kinase 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Cyclin Dependent Kinase 1 Sales by Country (2018-2023) & (K Pcs)
    Table 32. Europe Cyclin Dependent Kinase 1 Sales by Country (2024-2029) & (K Pcs)
    Table 33. Europe Cyclin Dependent Kinase 1 Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Cyclin Dependent Kinase 1 Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Cyclin Dependent Kinase 1 Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Cyclin Dependent Kinase 1 Sales by Region (2018-2023) & (K Pcs)
    Table 37. Asia Pacific Cyclin Dependent Kinase 1 Sales by Region (2024-2029) & (K Pcs)
    Table 38. Asia Pacific Cyclin Dependent Kinase 1 Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Cyclin Dependent Kinase 1 Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Cyclin Dependent Kinase 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Cyclin Dependent Kinase 1 Sales by Country (2018-2023) & (K Pcs)
    Table 42. Latin America Cyclin Dependent Kinase 1 Sales by Country (2024-2029) & (K Pcs)
    Table 43. Latin America Cyclin Dependent Kinase 1 Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Cyclin Dependent Kinase 1 Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Cyclin Dependent Kinase 1 Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Cyclin Dependent Kinase 1 Sales by Country (2018-2023) & (K Pcs)
    Table 47. Middle East & Africa Cyclin Dependent Kinase 1 Sales by Country (2024-2029) & (K Pcs)
    Table 48. Middle East & Africa Cyclin Dependent Kinase 1 Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Cyclin Dependent Kinase 1 Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Cyclin Dependent Kinase 1 Sales (K Pcs) by Type (2018-2023)
    Table 51. Global Cyclin Dependent Kinase 1 Sales (K Pcs) by Type (2024-2029)
    Table 52. Global Cyclin Dependent Kinase 1 Sales Market Share by Type (2018-2023)
    Table 53. Global Cyclin Dependent Kinase 1 Sales Market Share by Type (2024-2029)
    Table 54. Global Cyclin Dependent Kinase 1 Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Cyclin Dependent Kinase 1 Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Cyclin Dependent Kinase 1 Revenue Market Share by Type (2018-2023)
    Table 57. Global Cyclin Dependent Kinase 1 Revenue Market Share by Type (2024-2029)
    Table 58. Global Cyclin Dependent Kinase 1 Price (USD/Pcs) by Type (2018-2023)
    Table 59. Global Cyclin Dependent Kinase 1 Price (USD/Pcs) by Type (2024-2029)
    Table 60. Global Cyclin Dependent Kinase 1 Sales (K Pcs) by Application (2018-2023)
    Table 61. Global Cyclin Dependent Kinase 1 Sales (K Pcs) by Application (2024-2029)
    Table 62. Global Cyclin Dependent Kinase 1 Sales Market Share by Application (2018-2023)
    Table 63. Global Cyclin Dependent Kinase 1 Sales Market Share by Application (2024-2029)
    Table 64. Global Cyclin Dependent Kinase 1 Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Cyclin Dependent Kinase 1 Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Cyclin Dependent Kinase 1 Revenue Market Share by Application (2018-2023)
    Table 67. Global Cyclin Dependent Kinase 1 Revenue Market Share by Application (2024-2029)
    Table 68. Global Cyclin Dependent Kinase 1 Price (USD/Pcs) by Application (2018-2023)
    Table 69. Global Cyclin Dependent Kinase 1 Price (USD/Pcs) by Application (2024-2029)
    Table 70. Astex Pharmaceuticals Inc Corporation Information
    Table 71. Astex Pharmaceuticals Inc Description and Business Overview
    Table 72. Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 73. Astex Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product
    Table 74. Astex Pharmaceuticals Inc Recent Developments/Updates
    Table 75. ChoDang Pharm Co Ltd Corporation Information
    Table 76. ChoDang Pharm Co Ltd Description and Business Overview
    Table 77. ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 78. ChoDang Pharm Co Ltd Cyclin Dependent Kinase 1 Product
    Table 79. ChoDang Pharm Co Ltd Recent Developments/Updates
    Table 80. Presage Biosciences Inc Corporation Information
    Table 81. Presage Biosciences Inc Description and Business Overview
    Table 82. Presage Biosciences Inc Cyclin Dependent Kinase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 83. Presage Biosciences Inc Cyclin Dependent Kinase 1 Product
    Table 84. Presage Biosciences Inc Recent Developments/Updates
    Table 85. Tiziana Life Sciences Plc Corporation Information
    Table 86. Tiziana Life Sciences Plc Description and Business Overview
    Table 87. Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 88. Tiziana Life Sciences Plc Cyclin Dependent Kinase 1 Product
    Table 89. Tiziana Life Sciences Plc Recent Developments/Updates
    Table 90. Tragara Pharmaceuticals Inc Corporation Information
    Table 91. Tragara Pharmaceuticals Inc Description and Business Overview
    Table 92. Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 93. Tragara Pharmaceuticals Inc Cyclin Dependent Kinase 1 Product
    Table 94. Tragara Pharmaceuticals Inc Recent Developments/Updates
    Table 95. Key Raw Materials Lists
    Table 96. Raw Materials Key Suppliers Lists
    Table 97. Cyclin Dependent Kinase 1 Distributors List
    Table 98. Cyclin Dependent Kinase 1 Customers List
    Table 99. Cyclin Dependent Kinase 1 Market Trends
    Table 100. Cyclin Dependent Kinase 1 Market Drivers
    Table 101. Cyclin Dependent Kinase 1 Market Challenges
    Table 102. Cyclin Dependent Kinase 1 Market Restraints
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Cyclin Dependent Kinase 1
    Figure 2. Global Cyclin Dependent Kinase 1 Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Cyclin Dependent Kinase 1 Market Share by Type in 2022 & 2029
    Figure 4. AT-7519 Product Picture
    Figure 5. CD-650 Product Picture
    Figure 6. Milciclib Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Cyclin Dependent Kinase 1 Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 9. Global Cyclin Dependent Kinase 1 Market Share by Application in 2022 & 2029
    Figure 10. Relapsed Chronic Lymphocytic Leukemia
    Figure 11. Gliosarcoma
    Figure 12. Lymphoma
    Figure 13. Others
    Figure 14. Global Cyclin Dependent Kinase 1 Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Cyclin Dependent Kinase 1 Market Size (2018-2029) & (US$ Million)
    Figure 16. Global Cyclin Dependent Kinase 1 Sales (2018-2029) & (K Pcs)
    Figure 17. Global Cyclin Dependent Kinase 1 Average Price (USD/Pcs) & (2018-2029)
    Figure 18. Cyclin Dependent Kinase 1 Report Years Considered
    Figure 19. Cyclin Dependent Kinase 1 Sales Share by Manufacturers in 2022
    Figure 20. Global Cyclin Dependent Kinase 1 Revenue Share by Manufacturers in 2022
    Figure 21. The Global 5 and 10 Largest Cyclin Dependent Kinase 1 Players: Market Share by Revenue in 2022
    Figure 22. Cyclin Dependent Kinase 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 23. Global Cyclin Dependent Kinase 1 Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 24. North America Cyclin Dependent Kinase 1 Sales Market Share by Country (2018-2029)
    Figure 25. North America Cyclin Dependent Kinase 1 Revenue Market Share by Country (2018-2029)
    Figure 26. U.S. Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 27. Canada Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. Europe Cyclin Dependent Kinase 1 Sales Market Share by Country (2018-2029)
    Figure 29. Europe Cyclin Dependent Kinase 1 Revenue Market Share by Country (2018-2029)
    Figure 30. Germany Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. France Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. U.K. Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Italy Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Russia Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Asia Pacific Cyclin Dependent Kinase 1 Sales Market Share by Region (2018-2029)
    Figure 36. Asia Pacific Cyclin Dependent Kinase 1 Revenue Market Share by Region (2018-2029)
    Figure 37. China Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Japan Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. South Korea Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. India Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Australia Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Taiwan Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Indonesia Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Thailand Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Malaysia Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Philippines Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Latin America Cyclin Dependent Kinase 1 Sales Market Share by Country (2018-2029)
    Figure 48. Latin America Cyclin Dependent Kinase 1 Revenue Market Share by Country (2018-2029)
    Figure 49. Mexico Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Brazil Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Argentina Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Middle East & Africa Cyclin Dependent Kinase 1 Sales Market Share by Country (2018-2029)
    Figure 53. Middle East & Africa Cyclin Dependent Kinase 1 Revenue Market Share by Country (2018-2029)
    Figure 54. Turkey Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. Saudi Arabia Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 56. UAE Cyclin Dependent Kinase 1 Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 57. Global Sales Market Share of Cyclin Dependent Kinase 1 by Type (2018-2029)
    Figure 58. Global Revenue Market Share of Cyclin Dependent Kinase 1 by Type (2018-2029)
    Figure 59. Global Cyclin Dependent Kinase 1 Price (USD/Pcs) by Type (2018-2029)
    Figure 60. Global Sales Market Share of Cyclin Dependent Kinase 1 by Application (2018-2029)
    Figure 61. Global Revenue Market Share of Cyclin Dependent Kinase 1 by Application (2018-2029)
    Figure 62. Global Cyclin Dependent Kinase 1 Price (USD/Pcs) by Application (2018-2029)
    Figure 63. Cyclin Dependent Kinase 1 Value Chain
    Figure 64. Cyclin Dependent Kinase 1 Production Process
    Figure 65. Channels of Distribution (Direct Vs Distribution)
    Figure 66. Distributors Profiles
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS